Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 | P0DMS8 | 7/20 | 0.70 |
| ▸ | ADORA2A | P29274 | 6/20 | 0.70 |
| ▸ | ADORA1 | P30542 | 5/20 | 0.70 |
| ▸ | TSHR | P16473 | 3/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 3/20 | 0.70 |
| ▸ | TP53 | P04637 | 2/20 | 0.70 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.70 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.70 |
| ▸ | NPC1 | O15118 | 2/20 | 0.70 |
| ▸ | RAB9A | P51151 | 2/20 | 0.70 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.70 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.70 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.70 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.70 |
| ▸ | HPGD | P15428 | 1/20 | 0.70 |
| ▸ | SLC29A1 | Q99808 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | THPO | P40225 | 2/20 | 0.65 |
| ▸ | NPEPPS | P55786 | 1/20 | 0.65 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL855679 | 0.92 | SLC29A1 (0.61) | ADORA3ADORA2AADORA1TSHRNFKB1 | |
| SCHEMBL4125974 | 0.88 | P2RY12 (0.72) | ADORA1SMN1; SMN2 | |
| SCHEMBL30208574 | 0.88 | LMNA (0.60) | ADORA3ADORA2AADORA1TSHRNFKB1 | |
| SCHEMBL30208537 | 0.86 | LMNA (0.58) | ADORA3ADORA2AADORA1TSHRNFKB1 | |
| SCHEMBL30208584 | 0.86 | ADORA2A (0.59) | ADORA3ADORA2AADORA1ALDH1A1PMP22 | |
| SCHEMBL20626159 | 0.85 | ADORA3 (0.79) | ADORA3ADORA2AADORA1TSHRNFKB1 | |
| SCHEMBL20626158 | 0.85 | ADORA3 (0.79) | ADORA3ADORA2AADORA1TSHRNFKB1 | |
| SCHEMBL20626186 | 0.85 | ADORA3 (0.79) | ADORA3ADORA2AADORA1TSHRNFKB1 | |
| SCHEMBL14713382 | 0.85 | ADORA3 (0.79) | ADORA3ADORA2AADORA1TSHRNFKB1 | |
| SCHEMBL14713386 | 0.85 | ADORA3 (0.79) | ADORA3ADORA2AADORA1TSHRNFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240327822-A1 | MATERIALS AND METHODS TO COMPREHENSIVELY DEFINE ADAPTIVE IMMUNE RESPONSES | THE UNIVERSITY OF HONG KONG (CN) | 2024-10-03 | — | — | US | claimed |
| EP-4384614-A1 | MATERIALS AND METHODS TO COMPREHENSIVELY DEFINE ADAPTIVE IMMUNE RESPONSES | The University of Hong Kong (HK) | 2024-06-19 | — | — | EP | claimed |
| CN-118176298-A | Materials and methods for comprehensive definition of adaptive immune responses | 香港大学 | 2024-06-11 | — | — | CN | claimed |
| WO-2023016454-A1 | MATERIALS AND METHODS TO COMPREHENSIVELY DEFINE ADAPTIVE IMMUNE RESPONSES | THE UNIVERSITY OF HONG KONG (CN) | 2023-02-16 | — | — | WO | claimed |
| EP-2316030-B1 | PROTEIN SCREEING METHODS | WAGNER RICHARD W (US) | 2019-08-21 | — | — | EP | claimed |
| US-9803193-B2 | Protein screening methods | X-BODY, INC. (US) | 2017-10-31 | — | — | US | claimed |
| US-9134304-B2 | Protein screening methods | X-BODY, INC. (US) | 2015-09-15 | — | — | US | claimed |
| US-20140128275-A1 | COMPLEX OF NON-COVALENTLY BOUND PROTEIN WITH ENCODING NUCLEIC ACIDS AND USES THEREOF | Syndecion, LLC (US) | 2014-05-08 | — | — | US | claimed |
| US-8207093-B2 | Producing libraries; including high salt post translational incubation step | THE GENERAL HOSPITAL CORPORATION (US) | 2012-06-26 | — | — | US | claimed |
| EP-1712623-B1 | Selection of proteins using RNA-protein fusions | GEN HOSPITAL CORP (US) | 2011-10-19 | — | — | EP | claimed |
| US-6207446-B1 | MICROCHIP ARRAY OF IMMOBILIZED SINGLE-STRANDED NUCLEIC ACIDS WHICH ARE HYBRIDIZED TO RNA-PROTEIN FUSIONS; FUSIONS ARE RNA COVALENTLY BONDED TO 3' END OF PROTEIN THROUGH A PEPTIDE ACCEPTOR; PROTEIN IS ENCODED BY RNA; CYCLES OF SCREENING | THE GENERAL HOSPITAL CORPORATION | 2001-03-27 | — | — | US | claimed |
| EP-3775261-B1 | TARGET BINDING MOIETY COMPOSITIONS AND METHODS OF USE | GUANGZHOU CHENGYUAN BIOIMMUNOLOGY TECH CO LTD (CN) | 2025-09-17 | — | — | EP | disclosed |
| US-12116572-B2 | Target binding moiety compositions and methods of use | Guangzhou Chengyuan Bioimmunology Technology Co., Ltd. (CN) | 2024-10-15 | — | — | US | disclosed |
| US-20240327822-A1 | MATERIALS AND METHODS TO COMPREHENSIVELY DEFINE ADAPTIVE IMMUNE RESPONSES | THE UNIVERSITY OF HONG KONG (CN) | 2024-10-03 | — | — | US | disclosed |
| EP-4384614-A1 | MATERIALS AND METHODS TO COMPREHENSIVELY DEFINE ADAPTIVE IMMUNE RESPONSES | The University of Hong Kong (HK) | 2024-06-19 | — | — | EP | disclosed |
| WO-2001007657-A1 | PEPTIDE ACCEPTOR LIGATION METHODS | PHYLOS, INC. (US) | 2001-02-01 | — | — | WO | disclosed |
| WO-2000047775-A1 | SELECTION OF PROTEINS USING RNA-PROTEIN FUSIONS | THE GENERAL HOSPITAL CORPORATION (US) | 2000-08-17 | — | — | WO | disclosed |
| CN-1251593-A | Selection of proteins using RNA-protein fusions | GEN HOSPITAL CORP (US) | 2000-04-26 | — | — | CN | disclosed |
| EP-0971946-A1 | SELECTION OF PROTEINS USING RNA-PROTEIN FUSIONS | THE GENERAL HOSPITAL CORPORATION (US) | 2000-01-19 | — | — | EP | disclosed |
| WO-1998031700-A1 | SELECTION OF PROTEINS USING RNA-PROTEIN FUSIONS | THE GENERAL HOSPITAL CORPORATION (US) | 1998-07-23 | — | — | WO | disclosed |